首页> 外文期刊>Journal of neurology >Peripheral tumor necrosis factor-a-induced protein 8-like 2 mRNA level for predicting 3-month mortality of patients with acute ischemic stroke
【24h】

Peripheral tumor necrosis factor-a-induced protein 8-like 2 mRNA level for predicting 3-month mortality of patients with acute ischemic stroke

机译:外周肿瘤坏死因子 - 一种诱导的蛋白质8样2 mRNA水平,用于预测急性缺血性卒中患者的3个月死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor necrosis factor-a-induced protein 8-like 2 (TIPE2) is a novel negative regulator for maintaining immune homeostasis. This study aimed to investigate TIPE2 mRNA in peripheral blood mononuclear cells for predicting 3-month functional outcomes and mortality of patients with acute ischemic stroke. A total of 182 consecutive patients were prospective collected, and there were 55 (30.2%) patients with unfavorable outcome and 33 (18.1%) patients died at the end of 3?months. The area under the operating characteristic curve (AUC) for TIPE2 mRNA was 0.810 (95% CI 0.733–0.886) for mortality and 0.740 (95% CI 0.662–0.818) for unfavorable outcome. The model incorporating National Institutes of Health Stroke Scale (NIHSS) plus TIPE2 showed significantly ( P ?=?0.04) increased discrimination power (AUC?=?0.925, 95% CI 0.874–0.976) for mortality than NIHSS (AUC?=?0.882, 95% CI 0.833–0.932). Furthermore, NIHSS plus TIPE2 showed a significant improvement of both integrated discrimination index (IDI) and net reclassification index (NRI) as compared with NIHSS (IDI?=?0.224, 95% CI 0.150–0.299, P ?
机译:肿瘤坏死因子-A诱导的蛋白8状2(TIPE2)是一种用于维持免疫稳态的新型负调节剂。本研究旨在调查外周血单核细胞的TIPE2 mRNA,以预测急性缺血性卒中患者的3个月功能结果和死亡率。总共182名患者是预期收集的,并且有55例(30.2%)患者不利的结果,33例(18.1%)患者在3个月结束时死亡。用于TIPE2 mRNA的操作特性曲线(AUC)下的区域为死亡率为0.810(95%CI 0.733-0.886),为0.740(95%CI 0.662-0.818),以获得不利的结果。包含国家健康冲程量表(NIHSS)和TIPE2的模型显着显示(P?= 0.04)增加的歧视功率(AUC?= 0.925,95%CI 0.874-0.976)而不是NIHSS(AUC?= 0.882 ,95%CI 0.833-0.932))。此外,与NIHSS相比,NIHSS PLUS TIPE2显示出综合歧视指数(IDI)和净重新分类指数(NRI)的显着改善(IDI?= 0.224,95%CI 0.150-0.299,P?<0.001; NRI? =?1.119,95%CI 0.810-1.429,P?<0.001)。修剪的时间依赖树分析显示NIHSS的患者≥?5.5和TIPE2 mRNA?<?5.2具有相当高的3个月死亡率。总之,TIPE2 mRNA改善了NIHSS评分的诊断价值,NIHSS患者≥?5.5和TIPE2 mRNA?<?5.2具有高3个月的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号